Awaiting product image

Elysia Revance — Retatrutide Triple Receptor Agonist

Price range: $249.00 through $499.00

Retatrutide GLP-1/GIP/Glucagon tri-agonist · Lyophilized · 10 vials per box

SKU: N/A Category:

Revance contains Retatrutide, a triple hormone receptor agonist acting simultaneously on GLP-1, GIP, and glucagon receptors. Currently in Phase 3 clinical trials, Retatrutide represents the next generation of metabolic research peptides. Each box contains 10 vials of lyophilized powder.

Third-party COA available on request. For research purposes only.

Size

5mg x10 vials, 10mg x10 vials, 15mg x10 vials, 20mg x10 vials

Reviews

There are no reviews yet.

Be the first to review “Elysia Revance — Retatrutide Triple Receptor Agonist”

Your email address will not be published. Required fields are marked *

Related products

Scroll to Top